News
Video News
Mining Videos
News
Coin
Video News
Mining Videos
Search
Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win
4 hours ago
Argenx advances Vyvgart with strong trial data in seronegative gMG, driving growth projections and reinforcing its leadership in IgG-driven …
Read Entire Article
Homepage
News
Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win
Related
Ousted Maestro Charged in Child Sex Abuse Imagery Case
47 minutes ago
Trump Media Group Plans $6.4 Billion Deal to Buy Crypto.com ...
53 minutes ago
Global Exchanges Urge Crackdown on Tokenized Stocks Over Inv...
1 hour ago
Binance stablecoin inflows top $1.6B, signaling traders posi...
1 hour ago
EUR/USD Price Steadies As Traders Weigh Politics And U.S. Da...
1 hour ago
Bit Origin Ltd. Completes $6 Million Private Placement to Me...
1 hour ago
Trump is trying to fire a Fed governor. Here's what happened...
1 hour ago
Analyst Suggests Thinking Of XRP As Just ‘Payments’ Is Primi...
1 hour ago
Popular
Bitcoin Bears Take Control — Key $110K Barrier Shattered
23 hours ago
💡 TETHER'S MISSION: Paolo Ardoino on why Tether is "the stab...
23 hours ago
Making America the "Crypto Capital of the World" with Tether...
23 hours ago
Altcoin Season Is NOT Coming [Here's Why]
23 hours ago
XRP Credit Card Launches With up to 4% Back—Unlocks Full Rea...
22 hours ago
Japan’s Finance Chief Sees Crypto Playing Meaningful Role in...
19 hours ago